Drug Development for Dyslipidemia and Atherosclerosis
Measurement of Lipoproteins in Treatment with SPX-106
SPX106, A Novel Therapy for Dyslipidemia
Triglyceride Metabolism
Mechanism of Action of Resveratrol in Preventing LDL Oxidation
Synthesis of L-Tagatose for use as a Therapeutic Agent
Mechanism of Action of D-Tagatose in Adipocytes